Sandoz Group (OTCMKTS:SDZNY) Shares Gap Down – Time to Sell?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) gapped down before the market opened on Thursday . The stock had previously closed at $92.06, but opened at $87.82. Sandoz Group shares last traded at $87.68, with a volume of 510 shares.

Analysts Set New Price Targets

Separately, Barclays raised Sandoz Group from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Strong Buy”.

Sandoz Group Trading Up 0.2%

The company has a debt-to-equity ratio of 0.53, a current ratio of 1.18 and a quick ratio of 0.77. The firm’s 50-day moving average price is $85.77 and its 200 day moving average price is $83.68.

Sandoz Group Company Profile

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.